Global Recombinant Trypsin Solution Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 4262

Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
According to the form, the classification of recombinant trypsin solution includes solid type, liquid type. And the proportion of liquid type in 2017 is about 65.53%.
Recombinant trypsin solution is widely used for insulin manufacturing, vaccines manufacturing and cell culture. The most proportion of recombinant trypsin solution is used for cell culture, and the proportion in 2017 is about 39%.
Europe region is the largest supplier of recombinant trypsin solution, with a production market share nearly 66% in 2017. North America is the second largest supplier of recombinant trypsin solution, enjoying production market share nearly 27% in 2017.
North American is the largest consumption place, with a consumption market share nearly 42% in 2017. Following North American, North American is the second largest consumption place with the consumption market share of 33%.
The global Recombinant Trypsin Solution market is valued at 37 million US$ in 2018 and will reach 59 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Trypsin Solution market based on company, product type, end user and key regions.

This report studies the global market size of Recombinant Trypsin Solution in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Trypsin Solution in these regions.
This research report categorizes the global Recombinant Trypsin Solution market by top players/brands, region, type and end user. This report also studies the global Recombinant Trypsin Solution market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novozymes
Thermo Fisher
Roche
BBI Group
Merck
Biological Industries
Yaxin Bio
Lonza
Yocon Hengye Bio
Biosera
BasalMedia
Solarbio

Market size by Product
Solid
Liquid
Market size by End User
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Recombinant Trypsin Solution market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Recombinant Trypsin Solution market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Recombinant Trypsin Solution companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Recombinant Trypsin Solution submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Trypsin Solution are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K L). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Trypsin Solution market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Recombinant Trypsin Solution Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Trypsin Solution Market Size Growth Rate by Product
1.4.2 Solid
1.4.3 Liquid
1.5 Market by End User
1.5.1 Global Recombinant Trypsin Solution Market Size Growth Rate by End User
1.5.2 Insulin Manufacturing
1.5.3 Vaccines Manufacturing
1.5.4 Cell Culture
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Recombinant Trypsin Solution Market Size
2.1.1 Global Recombinant Trypsin Solution Revenue 2014-2025
2.1.2 Global Recombinant Trypsin Solution Sales 2014-2025
2.2 Recombinant Trypsin Solution Growth Rate by Regions
2.2.1 Global Recombinant Trypsin Solution Sales by Regions
2.2.2 Global Recombinant Trypsin Solution Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Recombinant Trypsin Solution Sales by Manufacturers
3.1.1 Recombinant Trypsin Solution Sales by Manufacturers
3.1.2 Recombinant Trypsin Solution Sales Market Share by Manufacturers
3.1.3 Global Recombinant Trypsin Solution Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Trypsin Solution Revenue by Manufacturers
3.2.1 Recombinant Trypsin Solution Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Trypsin Solution Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Trypsin Solution Price by Manufacturers
3.4 Recombinant Trypsin Solution Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Trypsin Solution Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Trypsin Solution Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Trypsin Solution Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Recombinant Trypsin Solution Sales by Product
4.2 Global Recombinant Trypsin Solution Revenue by Product
4.3 Recombinant Trypsin Solution Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Recombinant Trypsin Solution Breakdown Data by End User

6 North America
6.1 North America Recombinant Trypsin Solution by Countries
6.1.1 North America Recombinant Trypsin Solution Sales by Countries
6.1.2 North America Recombinant Trypsin Solution Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Trypsin Solution by Product
6.3 North America Recombinant Trypsin Solution by End User

7 Europe
7.1 Europe Recombinant Trypsin Solution by Countries
7.1.1 Europe Recombinant Trypsin Solution Sales by Countries
7.1.2 Europe Recombinant Trypsin Solution Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Trypsin Solution by Product
7.3 Europe Recombinant Trypsin Solution by End User

8 Asia Pacific
8.1 Asia Pacific Recombinant Trypsin Solution by Countries
8.1.1 Asia Pacific Recombinant Trypsin Solution Sales by Countries
8.1.2 Asia Pacific Recombinant Trypsin Solution Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Recombinant Trypsin Solution by Product
8.3 Asia Pacific Recombinant Trypsin Solution by End User

9 Central & South America
9.1 Central & South America Recombinant Trypsin Solution by Countries
9.1.1 Central & South America Recombinant Trypsin Solution Sales by Countries
9.1.2 Central & South America Recombinant Trypsin Solution Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Recombinant Trypsin Solution by Product
9.3 Central & South America Recombinant Trypsin Solution by End User

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Trypsin Solution by Countries
10.1.1 Middle East and Africa Recombinant Trypsin Solution Sales by Countries
10.1.2 Middle East and Africa Recombinant Trypsin Solution Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Trypsin Solution by Product
10.3 Middle East and Africa Recombinant Trypsin Solution by End User

11 Company Profiles
11.1 Novozymes
11.1.1 Novozymes Company Details
11.1.2 Company Business Overview
11.1.3 Novozymes Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novozymes Recombinant Trypsin Solution Products Offered
11.1.5 Novozymes Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Company Business Overview
11.2.3 Thermo Fisher Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Thermo Fisher Recombinant Trypsin Solution Products Offered
11.2.5 Thermo Fisher Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Recombinant Trypsin Solution Products Offered
11.3.5 Roche Recent Development
11.4 BBI Group
11.4.1 BBI Group Company Details
11.4.2 Company Business Overview
11.4.3 BBI Group Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BBI Group Recombinant Trypsin Solution Products Offered
11.4.5 BBI Group Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Company Business Overview
11.5.3 Merck Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck Recombinant Trypsin Solution Products Offered
11.5.5 Merck Recent Development
11.6 Biological Industries
11.6.1 Biological Industries Company Details
11.6.2 Company Business Overview
11.6.3 Biological Industries Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Biological Industries Recombinant Trypsin Solution Products Offered
11.6.5 Biological Industries Recent Development
11.7 Yaxin Bio
11.7.1 Yaxin Bio Company Details
11.7.2 Company Business Overview
11.7.3 Yaxin Bio Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Yaxin Bio Recombinant Trypsin Solution Products Offered
11.7.5 Yaxin Bio Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Company Business Overview
11.8.3 Lonza Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Lonza Recombinant Trypsin Solution Products Offered
11.8.5 Lonza Recent Development
11.9 Yocon Hengye Bio
11.9.1 Yocon Hengye Bio Company Details
11.9.2 Company Business Overview
11.9.3 Yocon Hengye Bio Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Yocon Hengye Bio Recombinant Trypsin Solution Products Offered
11.9.5 Yocon Hengye Bio Recent Development
11.10 Biosera
11.10.1 Biosera Company Details
11.10.2 Company Business Overview
11.10.3 Biosera Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Biosera Recombinant Trypsin Solution Products Offered
11.10.5 Biosera Recent Development
11.11 BasalMedia
11.12 Solarbio

12 Future Forecast
12.1 Recombinant Trypsin Solution Market Forecast by Regions
12.1.1 Global Recombinant Trypsin Solution Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Trypsin Solution Revenue Forecast by Regions 2019-2025
12.2 Recombinant Trypsin Solution Market Forecast by Product
12.2.1 Global Recombinant Trypsin Solution Sales Forecast by Product 2019-2025
12.2.2 Global Recombinant Trypsin Solution Revenue Forecast by Product 2019-2025
12.3 Recombinant Trypsin Solution Market Forecast by End User
12.4 North America Recombinant Trypsin Solution Forecast
12.5 Europe Recombinant Trypsin Solution Forecast
12.6 Asia Pacific Recombinant Trypsin Solution Forecast
12.7 Central & South America Recombinant Trypsin Solution Forecast
12.8 Middle East and Africa Recombinant Trypsin Solution Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Trypsin Solution Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer